Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal Transition

被引:16
|
作者
Meng, Lihong [1 ]
Zhang, Xiaomei [2 ]
Wang, Hong [3 ,4 ]
Dong, Huan [1 ]
Gu, Xiaofeng [1 ]
Yu, Xiaolin [1 ]
Liu, Yushan [1 ]
机构
[1] Beijing Univ Chinese Med, 11 North 3rd Ring Rd, Beijing 100029, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Dept Resp Med, 6 1st Dist Fangxingyuan, Beijing 100078, Peoples R China
[3] Shunyi Hosp, Beijing Chinese Med Hosp, 5 Zhanqian East St, Beijing 101300, Peoples R China
[4] Capital Med Univ, Beijing Chinese Med Hosp, Art Museum, 23 Houjie St, Beijing 100010, Peoples R China
关键词
MYOFIBROBLAST; ACTIVATION; MECHANISMS; RECEPTOR;
D O I
10.1155/2019/2710509
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-1/Smad signal pathway and epithelial to mesenchymal transition (EMT). Methods. 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-1, TRI, TRII, Smad3, Smad7, -SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. Results. TGF-1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-1, CTGF, hydroxyproline contents, and mRNA expression of TGF-1, TRI, TRII, Smad3, -SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. Conclusion. These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
    Chen, Y-L
    Zhang, X.
    Bai, J.
    Gai, L.
    Ye, X-L
    Zhang, L.
    Xu, Q.
    Zhang, Y-X
    Xu, L.
    Li, H-P
    Ding, X.
    CELL DEATH & DISEASE, 2013, 4 : e665 - e665
  • [32] Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition
    Zheng, Qing
    Tong, Ming
    Ou, Baiqing
    Liu, Cuizhong
    Hu, Changping
    Yang, Yu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (01) : 117 - 126
  • [33] Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
    Li, Jiang
    Wei, Qian
    Song, Ke
    Wang, Youxin
    Yang, Yuxin
    Li, Miao
    Yu, Jiaying
    Su, Guangxu
    Peng, Luyuan
    Fu, Bendong
    Yi, Pengfei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway
    Li, Xiaohe
    Wang, Yanhua
    Liang, Jingjing
    Bi, Zhun
    Ruan, Hao
    Cui, Yunyao
    Ma, Ling
    Wei, Yuli
    Zhou, Bingchen
    Zhang, Liang
    Zhou, Honggang
    Yang, Cheng
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5808 - 5822
  • [35] 2-aminopurine suppresses the TGF-β1-induced epithelial-mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis
    Weng, Dong
    Chen, Jian-xia
    Li, Hao-hao
    Liu, Feng
    Zhou, Li-dan
    Liu, Hai-peng
    Zheng, Rui-juan
    Jiang, Yan
    Liu, Zhong-hua
    Ge, Baoxue
    CELL DEATH DISCOVERY, 2018, 4
  • [36] Nintedanib Reduces Ventilation-Augmented Bleomycin-Induced Epithelial-Mesenchymal Transition And Pulmonary Fibrosis Through Suppressing The Src Pathway
    Li, L-F
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [37] All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats
    Song, Xiaodong
    Liu, Weili
    Xie, Shuyang
    Wang, Meirong
    Cao, Guohong
    Mao, Cuiping
    Lv, Changjun
    LABORATORY INVESTIGATION, 2013, 93 (11) : 1219 - 1231
  • [38] `Total glucosides of Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1/ Smad pathway and altering the MMP2/TIMP1 ratio
    Gao, Jian
    Feng, Li-Jie
    Liu, Gan
    Li, Ping
    Li, Jun
    Wu, Qiang
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 23 - 23
  • [39] Inhibition of Raf1 ameliorates bleomycin-induced pulmonary fibrosis through attenuation of TGF-β1 signaling
    Li, Shuang
    Liu, Jia
    Tan, Jiangning
    Li, Lian
    Kaltreider, Mary J.
    Zhao, Jing
    Kass, Daniel J.
    Shang, Dong
    Zhao, Yutong
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 315 (02) : L241 - L247
  • [40] Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition
    Se-Ruo Li
    Zhu-Xia Tan
    Yuan-Hua Chen
    Biao Hu
    Cheng Zhang
    Hua Wang
    Hui Zhao
    De-Xiang Xu
    Respiratory Research, 20